Journal profile · Endocrinology & Metabolism
Molecular and Cellular Endocrinology
ISSN 0303-7207 · eISSN 1872-8057 · Elsevier Ireland Ltd · NETHERLANDS · Monthly · Founded 1974
Molecular and Cellular Endocrinology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.37; hybrid open access; APC about USD 3,510; median 134 days to acceptance (104 articles, last 24 months); community-reported acceptance: about 38.75%; 169 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Molecular and Cellular Endocrinology is published by Elsevier Ireland Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Estrogen and related hormone effects, Growth Hormone and Insulin-like Growth Factors and Reproductive Biology and Fertility, together about 26% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Browse through a wide range of high-quality academic journals offered by Elsevier, including open access options, to enrich your research journey.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Main research topics OpenAlex counts of recent articles; shares are approximate
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology12%
- Growth Hormone and Insulin-like Growth FactorsMedicine7.8%
- Reproductive Biology and FertilityMedicine6.2%
- Hypothalamic control of reproductive hormonesMedicine5.6%
- Hormonal Regulation and HypertensionMedicine5%
- Pancreatic function and diabetesMedicine4.5%
- Adipose Tissue and MetabolismMedicine4.4%
- Hormonal and reproductive studiesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.37LetPub ·
- CiteScore 2026-06
- 7.4LetPub ·
- SJR 2026-06
- 1.23LetPub ·
- SNIP 2026-06
- 0.99LetPub ·
- h-index
- 131LetPub ·
- h-index
- 211OpenAlex ·
- i10-index
- 9,134OpenAlex ·
- 2-year mean citedness
- 3.73OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 20.91%LetPub ·
Volume
- Articles per year
- 147LetPub ·
Articles by year OpenAlex count · 12,655 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 138 | 47 | 41 |
| 2025 | 169 | 69 | 563 |
| 2024 | 198 | 83 | 1,278 |
| 2023 | 179 | 67 | 1,544 |
| 2022 | 162 | 67 | 3,161 |
| 2021 | 273 | 116 | 5,444 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
134 daysMedian, submission to acceptance · P25–P75 81 days – 186 days
- Acceptance to online
- median 1 days (104 articles)
- Submission to online
- median 136 days
- Sample
- 104 articles with submission and acceptance dates (354 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.2 monthsLetPub ·
- Average acceptance (community reports)
- 38.75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,510 / EUR 3,280 / GBP 2,810 / JPY 435,350 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Ireland Ltd
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Monthly
- Founded
- 1974
- ISSN
- 0303-7207
- Electronic ISSN
- 1872-8057
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Molecular and Cellular Endocrinology
What CAS zone is Molecular and Cellular Endocrinology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Molecular and Cellular Endocrinology is in Zone 2 of Medicine, and in Zone 3 of the minor category Cell Biology / Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Molecular and Cellular Endocrinology?
The latest impact factor listed by LetPub is 3.37; CiteScore 7.4, h-index 211.
How long does peer review take at Molecular and Cellular Endocrinology?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 134 days (interquartile range 81–186 days); authors report an average review time of about 2.2 months; the community-reported acceptance is “about 38.75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Molecular and Cellular Endocrinology?
According to LetPub and DOAJ records, Molecular and Cellular Endocrinology is indexed in SCIE and Scopus.
Is Molecular and Cellular Endocrinology open access, and what is the APC?
Molecular and Cellular Endocrinology is a hybrid journal. For open-access publication: APC about USD 3,510.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .